LNWTC
MEDP icon

Laird Norton Wetherby Trust Company’s Medpace MEDP Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
510
-2
-0.4% -$923 0.01% 900
2026
Q1 		$246K Buy
512
+33
+7% +$16.9K 0.01% 914
2025
Q4 		$269K Buy
+479
New +$272K 0.01% 916

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Laird Norton Wetherby Trust Company's MEDP Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Medpace (MEDP) stake by 0.39% in Q2 2026, selling an estimated $923 and leaving 510 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #900.

Laird Norton Wetherby Trust Company first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 510 shares of Medpace worth $270K as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 2 Medpace shares in Q2 2026, an estimated $923.
  • Medpace made up 0.01% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #900 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.